Citadel Advisors
AARD

Citadel Advisors’s Aardvark Therapeutics, Inc. Common Stock AARD Stock Holding History

Citadel Advisors’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$17.4M Buy
1,283,732
+9,648
+0.8% +$130K ﹤0.01% 1047
2025
Q1 		$9.44M Buy
+1,274,084
New +$9.44M ﹤0.01% 1287